Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Source filing unavailable
Q4 2012 · —
Revenue$3.26B$3.26B+5.5% vs Q4 2011 Net Income$376.40M$376.40M+30.3% vs Q4 2011 EPS Diluted$1.04$1.04+35.1% vs Q4 2011 Gross Profit$1,386,100,000+6.8% Operating Incomederived$400,600,000+15.0% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$660,100,000+3.6% Free Cash Flowderived$555,700,000−0.1% Margins · derivedGross margin42.5%+0.5 pt vs Q4 2011
Operating margin12.3%+1.0 pt vs Q4 2011
Net margin11.5%+2.2 pt vs Q4 2011